More than 50 Winship Cancer Institute of Emory University (Winship) investigators will be part of the ASCO20 Virtual Scientific Program, the annual meeting of the American Society of Clinical Oncology (ASCO). This virtual meeting replaces the on-site ASCO meeting that has been held in Chicago for years.
This year’s annual meeting will take place online, May 29 – May 31, and will include on-demand and scheduled scientific content. Approximately 2,215 abstracts were accepted for presentation during the ASCO20 Virtual Scientific Program, and more than 3,400 additional abstracts were accepted for online publication. Oral and poster presentations and sessions will be available on demand on Friday, May 29th.
"Winship's strong showing in ASCO's virtual program proves that the pandemic has not stopped our research productivity. We have adapted to this new way of presenting our work, and ASCO will showcase outstanding research from Winship oncologists at this critical time," says Winship Executive Director Walter J. Curran, Jr., MD, Lawrence W. Davis Chair in Radiation Oncology and Georgia Research Alliance Eminent Scholar and Chair in Cancer Research.
Winship oral presentations will be made by Ramalingam, who is senior or presenting author on three oral abstracts plus a poster discussion; medical oncologist Taofeek Owonikoko, MD, PhD, who will be a discussant in an oral abstract session on Chemo-immunotherapy in Small Cell Lung Cancer: Many Questions Remain; and Winship hematologist Ajay K. Nooka, MD, MPH, who will give an oral presentation on the DREAMM-6 study looking at a new combination therapy for multiple myeloma. Oral presentations are also being made by Winship pediatric oncologists with appointments at Children's Healthcare of Atlanta (Children's). Those include Muna Qayed, MD, MS and Kelly C. Goldsmith, MD, pediatric oncologists in the Aflac Cancer and Blood Disorders Center of Children’s and Emory Department of Pediatrics.
"We are proud to participate in this year's ASCO virtual program and present our opportunity to unite as a research community and advance the care we provide for children with cancer," says Douglas K. Graham, MD, PhD, Chief of the Aflac Cancer and Blood Disorders Center of Children's and the Daniel P. Amos Chair.
Winship and Children's investigators will present several poster discussion sessions, including one by Winship hematologist Jonathan Kaufman, MD, who will present a study on combination therapies for multiple myeloma.
Winship members will also be part of ASCO's scheduled programs on May 30th and May 31st. Of special note on May 30th are a Clinical Science Symposium on Cancer Care in the time of COVID, with Winship hematologist Mehmet Asim Bilen, MD; Nabil Saba, MD will be the discussant in the Highlights of the Day session on Head and Neck Cancer. On May 31st, a Highlights Session on Pediatric Oncology with Thomas Cash, MD, pediatric hematologist with the Aflac Cancer and Blood Disorders Center of Children’s. Also on May 31st, Winship Chief Medical Officer Sagar Lonial, MD is an author on the ENDURANCE Phase III trial comparing triple induction regimens for multiple myeloma that will be part of the Plenary Session.
Winship members are active on ASCO committees that are an important part of the annual meeting: Taofeek Owonikoko, MD, PhD, is chair elect of the Annual Meeting Education Committee, and Jane Meisel, MD, is a member of the Cancer Communications Committee.
Several Winship trainees and young faculty will receive awards during the conference, among them Katerina Mary Zakka, MD, recipient of a 2020 ASCO Annual Meeting Merit Award.